Literature DB >> 17227129

The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies.

Willem Maat1, Ekaterina S Jordanova, Shama L van Zelderen-Bhola, Ed R Barthen, Hans W Wessels, Nicoline E Schalij-Delfos, Martine J Jager.   

Abstract

CONTEXT: The detection of monosomy 3 in uveal melanomas has repeatedly been associated with adverse outcome. Fine-needle aspiration biopsy is being used to detect monosomy 3 in these tumors, based on the assumption that this chromosomal abnormality is distributed homogeneously throughout the tumor.
OBJECTIVE: To study the distribution of monosomy 3 in primary uveal melanoma by fluorescence in situ hybridization (FISH).
DESIGN: We studied 50 enucleated eyes with uveal melanoma. In all 50 tumors we performed cytogenetic analysis and FISH using a DNA-specific probe for the centromere region of chromosome 3 on cultured tumor cells. In addition, the percentage of tumor cells with monosomy 3 was assessed by FISH on nuclei, isolated from paraffin-embedded tissue and compared to results of FISH on regular histology sections of the paraffin-embedded tissue.
RESULTS: Combining karyotyping and FISH on cultured cells identified monosomy 3 in 19 (38%) of 50 tumors, whereas FISH on nuclei isolated from paraffin-embedded tissue showed 31 (62%) of 50 as having monosomy for chromosome 3. FISH analysis on paraffin sections showed tumor heterogeneity for copy number of chromosome 3 in at least 7 cases.
CONCLUSIONS: FISH analysis on paraffin sections shows that heterogeneity of monosomy of chromosome 3 is a frequent phenomenon in uveal melanoma. FISH on nuclei isolated from paraffin-embedded tissue identifies a higher frequency of monosomy 3 than the traditional combination of karyotyping and FISH on cultured uveal melanoma cells. The practice of assigning patients to risk categories based on fine-needle aspiration biopsy samples from primary uveal melanoma may be subject to error based on the heterogeneous distribution of monosomy 3 in these tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17227129     DOI: 10.5858/2007-131-91-THDOMI

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  30 in total

1.  Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration.

Authors:  Long V Ly; Inge H G Bronkhorst; Els van Beelen; Johannes Vrolijk; Andrew W Taylor; Mieke Versluis; Gregorius P M Luyten; Martine J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

2.  The molecular classification of uveal melanocytic lesions: an important discovery in context.

Authors:  Robert Folberg
Journal:  J Mol Diagn       Date:  2010-06-03       Impact factor: 5.568

3.  Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma.

Authors:  Mohamed H Abdel-Rahman; Benjamin N Christopher; Mohammed F Faramawi; Khaled Said-Ahmed; Carol Cole; Andrew McFaddin; Abhik Ray-Chaudhury; Nyla Heerema; Frederick H Davidorf
Journal:  Mod Pathol       Date:  2011-04-15       Impact factor: 7.842

4.  Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens.

Authors:  Benjamin N Christopher; Colleen M Cebulla; Paul E Wakely; Frederick H Davidorf; Mohamed H Abdel-Rahman
Journal:  Exp Eye Res       Date:  2011-09-17       Impact factor: 3.467

5.  Prognostic parameters in uveal melanoma and their association with BAP1 expression.

Authors:  T Huibertus van Essen; Sake I van Pelt; Mieke Versluis; Inge H G Bronkhorst; Sjoerd G van Duinen; Marina Marinkovic; Wilma G M Kroes; Claudia A L Ruivenkamp; Shruti Shukla; Annelies de Klein; Emine Kiliç; J William Harbour; Gregorius P M Luyten; Pieter A van der Velden; Rob M Verdijk; Martine J Jager
Journal:  Br J Ophthalmol       Date:  2014-08-21       Impact factor: 4.638

Review 6.  Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis).

Authors:  Martine J Jager; J Antonio Bermudez Magner; Bruce R Ksander; Sander R Dubovy
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

Review 7.  Recent developments in prognostic and predictive testing in uveal melanoma.

Authors:  Matthew G Field; J William Harbour
Journal:  Curr Opin Ophthalmol       Date:  2014-05       Impact factor: 3.761

Review 8.  Molecular pathology of uveal melanoma.

Authors:  S E Coupland; S L Lake; M Zeschnigk; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

9.  FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas.

Authors:  Laura Bonaldi; Edoardo Midena; Barbara Filippi; Elisabetta Tebaldi; Raffaella Marcato; Raffaele Parrozzani; Alberto Amadori
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

10.  FNA diagnosis of malignant melanoma-recurrent and metastatic disease.

Authors:  Kiran Alam; Anshu Jain; Meher Aziz; Aroonima Misra
Journal:  BMJ Case Rep       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.